Coronary artery intimal thickening in the transplanted heart: An in vivo intracoronary ultrasound study of immunologic and metabolic risk factors

Transplantation

Volumn 61, Issue 1, 1996, Pages 46-53

  Rickenbacher, Peter R ^a   Kemna, Mariska S ^a   Pinto, Fausto J ^a   Hunt, Sharon A ^a   Alderman, Edwin L ^a   Schroeder, John S ^a   Stinson, Edward B ^a   Popp, Richard L ^a,b   Chen, Ida ^a   Reaven, Gerald ^a   Valantine, Hannah A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CVIS Inc

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOCARDIOGRAPHY; ARTERY INTIMA PROLIFERATION; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; ECHOCARDIOGRAPHY; FEMALE; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; CORONARY ANGIOGRAPHY; CORONARY DISEASE; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; TUNICA INTIMA;

EID: 9044230531     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601150-00011     Document Type: Article

References (49)

1. Cooper DKC, Novitsky D, Hassoulas J, Chi B, Barnard C. Heart transplantation: the South African experience. Heart Transplant 1982; 2: 78.
2. Jamieson SW, Oyer PE, Baldwin J, Billingham M, Stinson E, Shumway N. Heart transplantation for end-stage ischemic heart disease: the Stanford experience. Heart Transplant 1984; 3: 224.
3. Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation 1987; 76: 827.
4. Narrod J, Kormos R, Armitage J, Hardesty R, Ladowski J, Griffith B. Acute rejection and coronary artery disease in long-term survivors of heart transplantation. J Heart Transplant 1989; 8: 418.
5. Olivari MT, Homans DC, Wilson RF, Kubo SH, Ring WS. Coronary artery disease in cardiac transplant patients receiving triple-drug immunosuppressive therapy. Circulation 1989; 80 (suppl 3): III-111.
6. Radovancevic B, Poindexter S, Birovljev S, et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardiothorac Surg 1990; 4: 309.
7. Schutz A, Kemkes BM, Kugler C, et al. The influence of rejection episodes on the development of coronary artery disease after heart transplantation. Eur J Cardiothorac Surg 1990; 4: 300.
8. Gao SZ, Schroeder JS, Alderman EL, et al. Clinical and laboratory correlates of accelerated coronary artery disease in cardiac transplant patients. Circulation 1987; 76 (suppl 5): V-56.
9. Gao SZ, Schroeder JS, Hunt SA, Valantine HA, Hill IR, Stinson EB. Influence of graft rejection on incidence of accelerated graft coronary artery disease: a new approach to analysis. J Heart Lung Transplant 1993; 12: 1029.
10. Ratkovec RM, Wray RB, Renlund DG, et al. Influence of corticosteroid-free maintenance immunosuppression on allograft coronary artery disease after cardiac transplantation. J Thorac Cardiovasc Surg 1990; 100: 6.
11. Stovin PG, Sharples L, Hutter JA, Wallwork J, English TA. Some prognostic factors for the development of transplant-related coronary artery disease in human cardiac allografts. J Heart Lung Transplant 1991; 10: 38.
12. Stovin PG, Sharples LD, Schofield PM, et al. Lack of association between endomyocardial evidence of rejection in the first six months and the later development of transplant-related coronary artery disease. J Heart Lung Transplant 1993; 12: 110.
13. Pollack MS, Ballantyne CM, Payton-Ross C. HLA match and other immunological parameters in relation to survival, rejection severity, and accelerated coronary artery disease after heart transplant. Clin Transplant 1990; 4: 269.
14. Rose EA, Pepino P, Barr ML, et al. Relation of HLA antibodies and graft atherosclerosis in human cardiac allograft recipients. J Heart Lung Transplant 1992; 11: S120.
15. Hammond EH, Yowell RL, Price GD, et al. Vascular rejection and its relationship to allograft coronary artery disease. J Heart Lung Transplant 1992; 11: S111.
16. Sharples LD, Caine N, Mullins P, et al. Risk factor analysis for the major hazards following heart transplantation - rejection, infection, and coronary occlusive disease. Transplantation 1991; 52: 244.
17. McDonald K, Rector TS, Braulin EA, Kubo SH, Olivari MT. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64: 359.
18. Winters GL, Kendall TJ, Radio SJ. Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant 1990; 9: 364.
19. Grattan MT, Moreno-Cabral CE, Starnes VA, Oyer PE, Stinson EB, Shumway NE. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA 1989; 261: 3561.
20. St Goar FG, Pinto FJ, Alderman EL, et al. Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening. Circulation 1992; 85: 979.
21. Valantine H, Pinto FJ, St Goar FG, Alderman EL, Popp RL. Intracoronary ultrasound imaging in heart transplant recipients: the Stanford experience. J Heart Lung Transplant 1992; 11: S60.
22. St. Goar FG, Pinto FJ, Alderman EL, Fitzgerald PJ, Stadius ML, Popp RL. Intravascular ultrasound imaging of angiographically normal coronary arteries: an in vivo comparison with quantitative angiography. J Am Coll Cardiol 1991; 18: 952.
23. Pinto FJ, Chenzbraun A, Botas J, et al. Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients. Circulation 1994; 90: 2348.
24. Kemna MS, Valantine HA, Hunt SA, Schroeder JS, Chen Y-DI, Reaven GM. Metabolic risk factors for atherosclerosis in heart transplant recipients. Am Heart J 1994; 128: 68.
25. Billingham ME. Diagnosis of cardiac rejection by endomyocardial biopsy. Heart Transplant 1981; 1: 25.
26. Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Lung Transplant 1990; 9: 587.
27. Fitzgerald PJ, St. Goar FG, Connolly AJ, et al. Intravascular ultrasound imaging of coronary arteries. Is three layers the norm? Circulation 1992; 86: 154.
28. Velican D, Velican C. Comparative study on age-related changes and atherosclerotic involvement of the coronary arteries of male and female subjects up to 40 years of age. Atherosclerosis 1981; 38: 39.
29. Johnson DE, Alderman EL, Schroeder JS, et al. Transplant coronary artery disease: histopathological correlations with angiographic morphology. J Am Coll Cardiol 1991; 17: 449.
30. Miller LW. Allograft vascular disease: a disease not limited to hearts. J Heart Lung Transplant 1992; 11: S32.
31. Lurie GK, Billingham ME, Jamieson SW, Harrison DC, Reitz BA. Pathogenesis and prevention of graft arteriosclerosis in an experimental heart transplant model. Transplantation 1981; 31: 41.
32. Laden AMK. The effects of treatment on the arterial lesions of rat and rabbit cardiac allografts. Transplantation 1972; 13: 281.
33. Gao SZ, Schroeder JS, Alderman EL, et al. Prevalence of accelerated coronary artery disease in heart transplant survivors: comparison of cyclosporine and azathioprine regimens. Circulation 1989; 89 (suppl 3): III-100.
34. Frist WH, Oyer PE, Baldwin JC, Stinson EB, Shumway NE. HLA compatibility and cardiac transplant recipient survival. Ann Thorac Surg 1987; 44: 242.
35. Radovancevic B, Birovljev S, Vega JD, et al. Inverse relationship between human leukocyte antigen match and development of coronary artery disease. Transplant Proc 1991; 23: 1144.
36. Anderson TJ, Meredith IT, Uehata A, Mudge GH, Selwyn AP, Yeung AC. Functional significance of intimal thickening as detected by intravascular ultrasound early and late after cardiac transplantation. Circulation 1993; 88: 1093.
37. Kemna MS, Valentine HA, Hunt SA, Schroeder JS, Chen Y-DI, Reaven GM. Metabolic risk factors for atherosclerosis in heart transplant recipients. Am Heart J 1994; 128: 68.
38. Stamler JS, Vaughan DE, Rudd MA, et al. Frequency of hypercholesterolemia after cardiac transplantation. Am J Cardiol 1988; 62: 1268.
39. Ballantyne CM, Radovancevic B, Farmer JA, et al. Hyperlipidemia after heart transplantation: report of a 6-year experience, with treatment recommendations. J Am Coll Cardiol 1992; 19: 1315.
40. Eich D, Thompson JA, Ko DJ, et al. Hypercholesterolemia in long-term survivors of heart transplantation: an early marker of accelerated coronary artery disease. J Heart Lung Transplant 1991; 10: 45.
41. Criqui MH, Heiss G, Cohn R, et al. Plasma triglyceride level and mortality from coronary heart disease. N Engl J Med 1993; 328: 1220.
42. Tanaka H, Sukhova GK, Libby P. Interaction of the allogeneic state and hypercholesterolemia in arterial lesion formation in experimental cardiac allografts. Arterioscler Thromb 1994; 14: 734.
43. Grady KL, Costanzo-Nordin MR, Herold LS, Sriniavasan S, Pifarre R. Obesity and hyperlipidemia after heart transplantation. J Heart Lung Transplant 1991; 10: 449.
44. Libby P, Salomon RN, Payne DD, Schoen FJ, Pober JS. Functions of vascular wall cells related to development of transplantation-associated coronary arteriosclerosis. Transplant Proc 1989; 21: 3677.
45. Hammond EH, Yowell RL, Nunoda S, et al. Vascular (humoral) rejection in heart transplantation: pathologic observations and clinical implications. J Heart Transplant 1989; 8: 430.
46. Cherry R, Nielsen H, Reed E, Reemtsma K, Suciu-Foca N, Marboe CC. Vascular (humoral) rejection in human cardiac allograft biopsies: relation to circulating anti-HLA antibodies. J Heart Lung Transplant 1992; 11: 24.
47. Hammond EH, Ensley RD, Yowell RL, et al. Vascular rejection of human cardiac allografts and the role of humoral immunity in chronic allograft rejection. Transplant Proc 1991; 23: 26.
48. Smart FW, Ballantyne CM, Cocanougher B, et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol 1991; 67: 243.
49. Collings CA, Pinto FJ, Valantine HA, Popylisen S, Puryear JV, Schnittger I. Exercise echocardiography in heart transplant recipients: a comparison with angiography and intracoronary ultrasonography. J Heart Lung Transplant 1994; 13: 604.